202 related articles for article (PubMed ID: 35784274)
1. HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis.
Dong ML; Wen X; He X; Ren JH; Yu HB; Qin YP; Yang Z; Yang ML; Zhou CY; Zhang H; Cheng ST; Chen J
Front Immunol; 2022; 13():871558. PubMed ID: 35784274
[TBL] [Abstract][Full Text] [Related]
2. RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.
Mao R; Dong M; Shen Z; Zhang H; Liu Y; Cai D; Mitra B; Zhang J; Guo H
J Virol; 2021 Sep; 95(19):e0044421. PubMed ID: 34287051
[TBL] [Abstract][Full Text] [Related]
3. HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis.
Wang Q; Cheng ST; Chen J
Int J Med Sci; 2020; 17(12):1783-1794. PubMed ID: 32714081
[No Abstract] [Full Text] [Related]
4. DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis.
Zhou HZ; Li F; Cheng ST; Xu Y; Deng HJ; Gu DY; Wang J; Chen WX; Zhou YJ; Yang ML; Ren JH; Zheng L; Huang AL; Chen J
Hepatology; 2022 Apr; 75(4):847-865. PubMed ID: 34626132
[TBL] [Abstract][Full Text] [Related]
5. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
6. MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma.
Jin C; Han-Hua D; Qiu-Meng L; Deng N; Peng-Chen D; Jie M; Lei X; Xue-Wu Z; Hui-Fang L; Yan C; Xiao-Ping C; Bi-Xiang Z
Oncogene; 2023 Jan; 42(3):169-183. PubMed ID: 36385375
[TBL] [Abstract][Full Text] [Related]
7. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.
Zhang H; Xing Z; Mani SK; Bancel B; Durantel D; Zoulim F; Tran EJ; Merle P; Andrisani O
Hepatology; 2016 Oct; 64(4):1033-48. PubMed ID: 27338022
[TBL] [Abstract][Full Text] [Related]
8. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
Xue Y; Jia X; Li C; Zhang K; Li L; Wu J; Yuan J; Li Q
Cell Death Dis; 2019 Oct; 10(11):814. PubMed ID: 31653828
[TBL] [Abstract][Full Text] [Related]
9. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
10. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
11. HBx and c-MYC Cooperate to Induce URI1 Expression in HBV-Related Hepatocellular Carcinoma.
Tsuchiya H; Amisaki M; Takenaga A; Honjo S; Fujiwara Y; Shiota G
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739577
[TBL] [Abstract][Full Text] [Related]
12. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
Zhao Q; Li T; Qi J; Liu J; Qin C
PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
[TBL] [Abstract][Full Text] [Related]
13. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
[TBL] [Abstract][Full Text] [Related]
14. The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma.
Xu Q; Gu S; Liang J; Lin Z; Zheng S; Yan J
Oncol Res; 2019 Mar; 27(4):509-514. PubMed ID: 29891022
[TBL] [Abstract][Full Text] [Related]
15. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
Front Immunol; 2021; 12():661204. PubMed ID: 33995383
[TBL] [Abstract][Full Text] [Related]
16. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
17. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
18. HBx-elevated SIRT2 promotes HBV replication and hepatocarcinogenesis.
Cheng ST; Ren JH; Cai XF; Jiang H; Chen J
Biochem Biophys Res Commun; 2018 Feb; 496(3):904-910. PubMed ID: 29366781
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
[TBL] [Abstract][Full Text] [Related]
20. TAGLN2, a novel regulator involved in Hepatitis B virus transcription and replication.
Yu Y; He Z; Cao Y; Tang H; Huang F
Biochem Biophys Res Commun; 2016 Sep; 477(4):1051-1058. PubMed ID: 27402267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
